Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Recently, mainly researching how to successfully execute "Hong Kong stock IPO arbitrage"?
Before the holiday, I registered a few @StableStock accounts, but due to system maintenance during the holiday, I didn't complete KYC.
Today, I drove over a hundred kilometers, looking for dad and mom, only then did I get all the account verifications done 😂
Now preparing to participate in two Hong Kong IPOs: Jitai Technology & Yingpai Pharmaceuticals
My approach is very simple:
🌟 Each account places a cash order (no financing)
🌟 Participate in platform activities (cash subscription fee refunded twice)
🌟 Increase the chances of winning the allocation
This method is not about betting on a surge, but:
👉 Controlling costs + increasing allocation wins + Riding the sentiment
As long as I get one allocation, it's basically a positive return.
Of course, there are a few risks:
1) Pharmaceutical stocks are mainly driven by sentiment, not fundamentals
2) Subscription multiples are crucial; if it's not popular, don't touch it
3) Platform opportunities require good control of funds
I participate with a light position, mainly testing arbitrage.
If you're also interested in this low-risk IPO strategy, you can use my invitation:
👉 40% rebate, all given to me (pure sharing)
After these two IPOs go public, I will review the results.